The Florida Agency for Health Care Administration’s rules state that Medicaid does not cover services for treatments such as puberty blocking-medications, hormone therapies or surgical procedures as a treatment for gender dysphoria, according to the report.
The rule will take effect Aug. 21, according to the report.
A coalition of LGBTQ and health rights groups criticized the rule, stating it will leave thousands of youth and adult transgender Floridians without critical care when they need it most, according to the report.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.